Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (9801)	5/5/1999 10:31:00 PM
From: Bluegreen	Respond to of 17367

Why has Murphy been silent on Xoma last two regular hotlines? It was good to see John still hanging around and I wondered what his group was doing lately on stock picks.

To: aknahow who wrote (9801)	5/5/1999 11:01:00 PM
From: Bluegreen	Read Replies (2) \| Respond to of 17367

Oh, almost forgot. Murphy states in latest newsletter "we continue to think this drug works spectacularly well and will generate strongly significant results. Wall street would rather pay $10 for it after the results are out and ride it to $20 than buy it at $3 and take a chance it will go to $1 if the trial doesn't work. We are buying it here." George, what does he mean by trial doesn't work? Wouldn't the DSMB have stopped the trial if the efficacy wasn't there? If mortality isn't reached and Xoma stops anyway, then why did Xoma or FDA call it a REQUIREMENT? These questions need to be answered. I could see saying we have mortality target that would be nice to hit but doesn't mean it can't be approved anyway. SL, once again, can I bring up the word whimsical again in regard to FDA's idea of efficacy? I can't see where you would find a better example of extracting pound of flesh for a whimsical "requirement." Keep in mind the above is predicated on IF Xoma ends trial and goes to FDA without the "requirement" being met. Ok, George do YOU think they will get the "requirement" number before ending the trial? ONLY MY OPINION BUT I PREDICT NO WAY WILL THEY REACH THE "REQUIREMENT" NUMBER BEFORE STOPPING THE TRIAL! That is only wild unsubstantiated speculation on my part. Which takes us back to annual report of being "on target." I didn't see anything stated about size of target and bull's eye!